Infervision

Infervision is a world's leading high-tech enterprise in medical artificial intelligence. Aiming to empower doctors with higher efficiency and benefit patients with better diagnosis, outcome and lower cost, Infervision is using A.I. and deep learning technologies to develop multiple platforms, including an A.I. applications management platform, an A.I. data-mining research platform, and several A.I. clinical application platforms, as well as medical A.I. systems for quality control, health management, and scientific research. Infervision provides advanced, intelligent, and systematic services to payor, provider, and patients, and truly realizes "Advancing Technology, Inspiring Healthcare."

As of November 2020, Infervision has service-sites covering North America, Asia-Pacific and Europe region, with the presence in over twenty countries worldwide.  By 2020, Infervision's AI products have gained several regulatory clearances, including PMDA in Japan, CE, the FDA 510(k), and the NMPA of China.